CN Stock MarketDetailed Quotes

Nanjing Vishee Medical Technology Co., Ltd (688580)

Watchlist
  • 61.90
  • -2.36-3.67%
Market Closed May 6 15:00 CST
5.93BMarket Cap35.62P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nanjing Vishee Medical Technology Co., Ltd (688580) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
10.56%106.04M
15.66%462.73M
11.58%325.53M
9.85%210.45M
9.40%95.91M
-13.45%400.06M
-12.06%291.76M
-12.84%191.58M
-8.24%87.67M
43.72%462.22M
Operating revenue
10.56%106.04M
15.66%462.73M
11.58%325.53M
9.85%210.45M
9.40%95.91M
-13.45%400.06M
-12.06%291.76M
-12.84%191.58M
-8.24%87.67M
43.72%462.22M
Total operating cost
12.42%74.64M
6.04%344.48M
1.73%235.85M
-3.16%149.77M
-8.26%66.4M
-6.40%324.85M
-5.80%231.83M
-1.88%154.66M
1.60%72.38M
40.48%347.04M
Operating cost
12.20%35.89M
13.19%156.46M
9.55%107.88M
8.93%71.37M
5.55%31.98M
-7.33%138.23M
3.87%98.48M
4.15%65.51M
10.87%30.3M
68.51%149.16M
Operating tax surcharges
76.08%2.49M
19.29%6.6M
22.08%4.85M
12.81%2.97M
10.43%1.41M
-3.39%5.53M
-1.09%3.97M
-5.84%2.64M
-0.62%1.28M
43.77%5.73M
Operating expense
5.66%15.7M
-2.72%91.8M
-4.49%61.11M
-9.89%37.02M
-17.72%14.86M
-10.11%94.37M
-26.91%63.98M
-27.92%41.09M
-30.15%18.06M
14.69%104.99M
Administration expense
13.42%10.81M
6.31%47.36M
-2.94%32.65M
-17.87%19.83M
-25.09%9.53M
-6.20%44.55M
1.64%33.64M
24.42%24.14M
31.75%12.72M
24.42%47.49M
Financial expense
3.00%-1.02M
66.22%-2.85M
71.22%-2.35M
74.44%-1.9M
80.62%-1.05M
53.03%-8.45M
45.76%-8.17M
26.81%-7.45M
-16.90%-5.41M
4.88%-17.98M
-Interest expense (Financial expense)
-98.62%4.84K
-0.05%1.31M
8.78%1.05M
9.04%701.88K
9.13%351.26K
-0.74%1.31M
-3.83%965.57K
1.78%643.72K
-1.59%321.86K
294.72%1.32M
-Interest Income (Financial expense)
23.69%-1.07M
56.89%-4.21M
62.54%-3.43M
67.77%-2.62M
75.43%-1.4M
49.40%-9.77M
43.08%-9.15M
25.12%-8.11M
-15.75%-5.71M
-0.18%-19.32M
Research and development
11.54%10.78M
-10.86%45.12M
-20.58%31.71M
-28.71%20.48M
-37.36%9.66M
-12.21%50.61M
-4.26%39.93M
11.80%28.73M
31.42%15.43M
31.83%57.65M
Credit Impairment Loss
218.34%99.63K
34.51%-835.77K
-11.92%-149.23K
-29.46%-180.91K
-645.77%-84.19K
41.68%-1.28M
49.37%-133.33K
-146.10%-139.75K
-117.72%-11.29K
-222.02%-2.19M
Asset Impairment Loss
----
-1,373.01%-430.63K
---122.97K
----
----
---29.23K
----
----
----
----
Other net revenue
Fair value change income
----
99.85%4.84M
----
----
----
350.97%2.42M
----
----
----
---964.05K
Invest income
-18.41%2.55M
10.55%12.53M
18.51%9.76M
31.78%6.59M
175.78%3.13M
7.16%11.34M
15.34%8.24M
-0.68%5M
-64.96%1.13M
-33.92%10.58M
Asset deal income
3,716,846.37%32.14M
-122.52%-880.57
-298.78%-864.63
-298.78%-864.63
---864.63
285.01%3.91K
-88.60%434.96
-88.60%434.96
----
---2.11K
Other revenue
-6.81%4.18M
-24.58%17.98M
-17.70%13.44M
-16.06%9.3M
-27.72%4.49M
-7.73%23.84M
-14.01%16.33M
14.07%11.07M
33.57%6.21M
77.68%25.83M
Operating profit
89.96%70.37M
36.61%152.32M
33.49%112.61M
44.52%76.39M
63.73%37.04M
-24.88%111.5M
-24.36%84.36M
-31.23%52.86M
-29.86%22.62M
42.11%148.44M
Add:Non operating Income
-51.46%2.21K
19.04%2.2M
92.24%276.47K
31.36%155.02K
-95.53%4.56K
14.56%1.85M
-79.33%143.81K
-82.41%118.01K
-84.06%102.05K
12.86%1.61M
Less:Non operating expense
--2.21K
26.86%89.86K
-52.73%13.49K
-59.35%11.6K
----
67.48%70.83K
-36.96%28.53K
-36.73%28.53K
----
-4.69%42.29K
Total profit
89.94%70.37M
36.33%154.43M
33.62%112.87M
44.55%76.54M
63.02%37.05M
-24.49%113.28M
-24.70%84.48M
-31.67%52.95M
-30.85%22.73M
41.73%150.01M
Less:Income tax cost
129.76%8.79M
44.65%16.36M
70.00%10.73M
116.73%7.21M
293.56%3.83M
-17.77%11.31M
-39.94%6.31M
-51.99%3.33M
-65.05%972.31K
14.47%13.75M
Net profit
85.35%61.57M
35.41%138.07M
30.68%102.15M
39.71%69.32M
52.71%33.22M
-25.16%101.97M
-23.13%78.17M
-29.67%49.62M
-27.69%21.75M
45.22%136.26M
Net profit from continuing operation
85.35%61.57M
35.41%138.07M
30.68%102.15M
39.71%69.32M
52.71%33.22M
-25.16%101.97M
-23.13%78.17M
-29.67%49.62M
-27.69%21.75M
45.22%136.26M
Net profit of parent company owners
85.35%61.57M
35.41%138.07M
30.68%102.15M
39.71%69.32M
52.71%33.22M
-25.16%101.97M
-23.13%78.17M
-29.67%49.62M
-27.69%21.75M
45.22%136.26M
Earning per share
Basic earning per share
82.86%0.64
34.58%1.44
30.49%1.07
38.46%0.72
53.31%0.35
-24.96%1.07
-23.08%0.82
-29.69%0.52
-48.18%0.2283
3.79%1.426
Diluted earning per share
82.86%0.64
34.58%1.44
30.49%1.07
38.46%0.72
53.58%0.35
-24.84%1.07
-23.02%0.82
-29.67%0.52
-48.28%0.2279
3.69%1.4237
Other composite income
Total composite income
85.35%61.57M
35.41%138.07M
30.68%102.15M
39.71%69.32M
52.71%33.22M
-25.16%101.97M
-23.13%78.17M
-29.67%49.62M
-27.69%21.75M
45.22%136.26M
Total composite income of parent company owners
85.35%61.57M
35.41%138.07M
30.68%102.15M
39.71%69.32M
52.71%33.22M
-25.16%101.97M
-23.13%78.17M
-29.67%49.62M
-27.69%21.75M
45.22%136.26M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
--
--
--
--
Unqualified opinion
Auditor
--
--
--
--
--
--
--
--
--
Tianheng Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue 10.56%106.04M15.66%462.73M11.58%325.53M9.85%210.45M9.40%95.91M-13.45%400.06M-12.06%291.76M-12.84%191.58M-8.24%87.67M43.72%462.22M
Operating revenue 10.56%106.04M15.66%462.73M11.58%325.53M9.85%210.45M9.40%95.91M-13.45%400.06M-12.06%291.76M-12.84%191.58M-8.24%87.67M43.72%462.22M
Total operating cost 12.42%74.64M6.04%344.48M1.73%235.85M-3.16%149.77M-8.26%66.4M-6.40%324.85M-5.80%231.83M-1.88%154.66M1.60%72.38M40.48%347.04M
Operating cost 12.20%35.89M13.19%156.46M9.55%107.88M8.93%71.37M5.55%31.98M-7.33%138.23M3.87%98.48M4.15%65.51M10.87%30.3M68.51%149.16M
Operating tax surcharges 76.08%2.49M19.29%6.6M22.08%4.85M12.81%2.97M10.43%1.41M-3.39%5.53M-1.09%3.97M-5.84%2.64M-0.62%1.28M43.77%5.73M
Operating expense 5.66%15.7M-2.72%91.8M-4.49%61.11M-9.89%37.02M-17.72%14.86M-10.11%94.37M-26.91%63.98M-27.92%41.09M-30.15%18.06M14.69%104.99M
Administration expense 13.42%10.81M6.31%47.36M-2.94%32.65M-17.87%19.83M-25.09%9.53M-6.20%44.55M1.64%33.64M24.42%24.14M31.75%12.72M24.42%47.49M
Financial expense 3.00%-1.02M66.22%-2.85M71.22%-2.35M74.44%-1.9M80.62%-1.05M53.03%-8.45M45.76%-8.17M26.81%-7.45M-16.90%-5.41M4.88%-17.98M
-Interest expense (Financial expense) -98.62%4.84K-0.05%1.31M8.78%1.05M9.04%701.88K9.13%351.26K-0.74%1.31M-3.83%965.57K1.78%643.72K-1.59%321.86K294.72%1.32M
-Interest Income (Financial expense) 23.69%-1.07M56.89%-4.21M62.54%-3.43M67.77%-2.62M75.43%-1.4M49.40%-9.77M43.08%-9.15M25.12%-8.11M-15.75%-5.71M-0.18%-19.32M
Research and development 11.54%10.78M-10.86%45.12M-20.58%31.71M-28.71%20.48M-37.36%9.66M-12.21%50.61M-4.26%39.93M11.80%28.73M31.42%15.43M31.83%57.65M
Credit Impairment Loss 218.34%99.63K34.51%-835.77K-11.92%-149.23K-29.46%-180.91K-645.77%-84.19K41.68%-1.28M49.37%-133.33K-146.10%-139.75K-117.72%-11.29K-222.02%-2.19M
Asset Impairment Loss -----1,373.01%-430.63K---122.97K-----------29.23K----------------
Other net revenue
Fair value change income ----99.85%4.84M------------350.97%2.42M---------------964.05K
Invest income -18.41%2.55M10.55%12.53M18.51%9.76M31.78%6.59M175.78%3.13M7.16%11.34M15.34%8.24M-0.68%5M-64.96%1.13M-33.92%10.58M
Asset deal income 3,716,846.37%32.14M-122.52%-880.57-298.78%-864.63-298.78%-864.63---864.63285.01%3.91K-88.60%434.96-88.60%434.96-------2.11K
Other revenue -6.81%4.18M-24.58%17.98M-17.70%13.44M-16.06%9.3M-27.72%4.49M-7.73%23.84M-14.01%16.33M14.07%11.07M33.57%6.21M77.68%25.83M
Operating profit 89.96%70.37M36.61%152.32M33.49%112.61M44.52%76.39M63.73%37.04M-24.88%111.5M-24.36%84.36M-31.23%52.86M-29.86%22.62M42.11%148.44M
Add:Non operating Income -51.46%2.21K19.04%2.2M92.24%276.47K31.36%155.02K-95.53%4.56K14.56%1.85M-79.33%143.81K-82.41%118.01K-84.06%102.05K12.86%1.61M
Less:Non operating expense --2.21K26.86%89.86K-52.73%13.49K-59.35%11.6K----67.48%70.83K-36.96%28.53K-36.73%28.53K-----4.69%42.29K
Total profit 89.94%70.37M36.33%154.43M33.62%112.87M44.55%76.54M63.02%37.05M-24.49%113.28M-24.70%84.48M-31.67%52.95M-30.85%22.73M41.73%150.01M
Less:Income tax cost 129.76%8.79M44.65%16.36M70.00%10.73M116.73%7.21M293.56%3.83M-17.77%11.31M-39.94%6.31M-51.99%3.33M-65.05%972.31K14.47%13.75M
Net profit 85.35%61.57M35.41%138.07M30.68%102.15M39.71%69.32M52.71%33.22M-25.16%101.97M-23.13%78.17M-29.67%49.62M-27.69%21.75M45.22%136.26M
Net profit from continuing operation 85.35%61.57M35.41%138.07M30.68%102.15M39.71%69.32M52.71%33.22M-25.16%101.97M-23.13%78.17M-29.67%49.62M-27.69%21.75M45.22%136.26M
Net profit of parent company owners 85.35%61.57M35.41%138.07M30.68%102.15M39.71%69.32M52.71%33.22M-25.16%101.97M-23.13%78.17M-29.67%49.62M-27.69%21.75M45.22%136.26M
Earning per share
Basic earning per share 82.86%0.6434.58%1.4430.49%1.0738.46%0.7253.31%0.35-24.96%1.07-23.08%0.82-29.69%0.52-48.18%0.22833.79%1.426
Diluted earning per share 82.86%0.6434.58%1.4430.49%1.0738.46%0.7253.58%0.35-24.84%1.07-23.02%0.82-29.67%0.52-48.28%0.22793.69%1.4237
Other composite income
Total composite income 85.35%61.57M35.41%138.07M30.68%102.15M39.71%69.32M52.71%33.22M-25.16%101.97M-23.13%78.17M-29.67%49.62M-27.69%21.75M45.22%136.26M
Total composite income of parent company owners 85.35%61.57M35.41%138.07M30.68%102.15M39.71%69.32M52.71%33.22M-25.16%101.97M-23.13%78.17M-29.67%49.62M-27.69%21.75M45.22%136.26M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------------------Unqualified opinion
Auditor ------------------Tianheng Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.45%
Sample Name
Sample Code
 +4.80%
Sample Name
Sample Code
 +3.86%
4
CNOOC
00883
+3.77%
5
SINOPEC CORP
00386
+2.61%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +61.02%
Sample Name
Sample Code
 +51.07%
Sample Name
Sample Code
 +40.94%
4
Business-intelligence Of Oriental Nations Corporation
300166
+33.12%
5
Emdoor Information
001314
+32.98%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to the latest report by AXIOS, the US expects Iran to respond on several key issues within the next 48 hours. No agreement has bee Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -